Mohawk Industries
MHK
$108.04
-3.12%
Mohawk Industries is a leading global manufacturer of flooring products, including carpets, rugs, ceramic tile, laminate, wood, and luxury vinyl tile, operating in the Consumer Cyclical sector's furnishings and fixtures industry. The company is a dominant player in the flooring market, distinguished by its extensive vertical integration, diverse brand portfolio, and global manufacturing footprint across its three primary segments: Global Ceramic, Flooring North America, and Flooring Rest of the World. The current investor narrative centers on navigating a cyclical downturn in the housing and remodeling markets, with recent financial results showing significant pressure on profitability, which has sparked debate around the company's ability to manage costs and maintain its competitive position in a challenging demand environment.…
MHK
Mohawk Industries
$108.04
Investment Opinion: Should I buy MHK Today?
Hold. The stock presents a classic 'value trap' scenario—attractive on traditional valuation metrics but facing significant near-term earnings headwinds that justify caution.
The case for a Hold is supported by four key data points: 1) The stock trades at a deep discount on a Price-to-Sales basis (P/S of 0.63) and below book value (P/B of 0.81), suggesting limited downside if the balance sheet holds. 2) Strong TTM free cash flow of $616.2 million provides a financial cushion. 3) Analyst consensus implies a forward P/E of 10.87x, pricing in a significant earnings recovery to an estimated $15.73 EPS. 4) However, the severe profitability collapse (Q4 net income down 61% YoY) and compressed operating margin of 3.71% validate the market's skepticism, capping near-term upside.
The rating would upgrade to Buy if operating margins show sequential improvement for two consecutive quarters, signaling the trough is in, or if the stock price falls decisively below $95, offering a greater margin of safety. It would downgrade to Sell if Q4's margin compression proves not to be the bottom, with operating margins falling below 3.5% in the next quarter, or if revenue growth turns negative. Relative to its history and the challenged near-term fundamentals, the stock appears fairly valued, trading at a discount to sales but a premium to depressed earnings.
Sign up to view all
MHK 12-Month Price Forecast
Mohawk is a battleground stock caught between deeply discounted valuation and severely depressed fundamentals. The AI assessment is neutral with medium confidence, as the outcome hinges entirely on the trajectory of operating margins in the coming quarters. The strong balance sheet and cash flow generation limit catastrophic downside, but the path to meaningful earnings recovery is unclear in a soft demand environment. The stance would upgrade to bullish on evidence of sustained margin improvement (e.g., two consecutive quarters of operating margin expansion) or a further price decline below $95 that enhances the margin of safety. It would downgrade to bearish if the next quarterly report shows further margin compression or a revenue decline, invalidating the stabilization thesis.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Mohawk Industries's 12-month outlook, with a consensus price target around $140.45 and implied upside of +30.0% versus the current price.
Average Target
$140.45
3 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
3
covering this stock
Price Range
$86 - $140
Analyst target range
Analyst coverage for Mohawk is limited, with only 3 analysts providing estimates, indicating this is not a widely followed large-cap stock. The consensus sentiment appears neutral to cautious, as reflected in recent institutional ratings which include actions like 'Sector Perform', 'In Line', and 'Equal Weight', with only one 'Buy' rating from Truist Securities. A notable downgrade occurred in January 2026 when Wolfe Research moved from 'Outperform' to 'Peer Perform'. The average revenue estimate for the coming period is approximately $12.06 billion, with an average EPS estimate of $15.73, ranging from a low of $15.29 to a high of $16.04. The target price range is not explicitly provided in the data, but the implied valuation based on the forward P/E and estimated EPS suggests a target around $171, which would represent significant upside from the current price. However, the wide dispersion in recent analyst actions—from 'Buy' to 'Hold' to 'Peer Perform'—and the limited number of covering analysts signal high uncertainty and a lack of strong conviction. This limited coverage is typical for a mid-cap, cyclical industrial company and can lead to higher volatility and less efficient price discovery, as the stock may be more influenced by broader market sentiment and industry trends than by detailed fundamental analysis from a large analyst community.
Bulls vs Bears: MHK Investment Factors
The evidence currently tilts bearish, as the severe and rapid deterioration in profitability (net income down 61% YoY) outweighs the attractive valuation and strong balance sheet. The most critical tension in the investment debate is whether the current cyclical downturn represents a temporary earnings trough from which Mohawk can recover, justifying its low P/S and P/B multiples, or a more permanent impairment of its earnings power due to structural margin pressures. The stock's fate hinges on the trajectory of operating margins, which collapsed to 3.71% in the latest quarter. If margins stabilize and begin to recover, the significant discount to historical valuation and strong free cash flow could drive a powerful rally. However, if margins remain depressed, the stock's low multiples may prove to be a value trap.
Bullish
- Strong Free Cash Flow & Balance Sheet: The company generated $616.2 million in TTM free cash flow, providing ample liquidity to navigate the downturn. A healthy current ratio of 2.19 and a low debt-to-equity ratio of 0.33 offer significant financial flexibility and reduce bankruptcy risk.
- Deeply Discounted Valuation on Sales: The stock trades at a Price-to-Sales (P/S) ratio of 0.63, which is low and suggests the market has priced in significant pessimism. The Price-to-Book (P/B) ratio of 0.81 is near historical lows, indicating a potential margin of safety if fundamentals stabilize.
- Significant Forward P/E Compression: The forward P/E of 10.87x, based on analyst EPS estimates of $15.73, is a 41% discount to the trailing P/E of 18.35x. This large gap implies the market expects a substantial earnings recovery, offering upside if the company meets or exceeds depressed expectations.
- Dominant Market Position & Diversification: As a leading global manufacturer with a diversified portfolio across ceramic, carpet, laminate, and wood flooring, Mohawk benefits from scale and vertical integration. Its largest segment, Global Ceramic, generated $1.06 billion in Q4 2025, providing a stable revenue base.
Bearish
- Severe Profitability Collapse: Net income plummeted 61% YoY to $42 million in Q4 2025 from $93.2 million in Q4 2024, with operating margin compressing to 3.71% from 4.92%. This dramatic decline in earnings power is the core of the bear case, questioning the company's ability to manage costs.
- Cyclical Downturn & Weak Demand: The company is exposed to the cyclical housing and remodeling markets, which are currently weak. Revenue growth decelerated to 2.37% YoY in Q4 2025 from stronger prior quarters, indicating persistent top-line pressure in a challenging demand environment.
- High Volatility & Technical Downtrend: The stock has a beta of 1.21 and a high short interest ratio of 4.68, making it prone to sharp moves. It is trading 24.8% below its 52-week high and has underperformed the S&P 500 by 20.1% over the past year, reflecting persistent negative momentum.
- Limited Analyst Conviction & Coverage: Only 3 analysts cover the stock, with recent actions including a downgrade to 'Peer Perform' and a mix of 'Hold' and 'Equal Weight' ratings. This limited coverage and lack of strong bullish consensus signal high uncertainty and can lead to inefficient price discovery.
MHK Technical Analysis
The stock is in a pronounced downtrend and is trading near the bottom of its 52-week range. With a current price of $107.64, it sits just 15.8% above its 52-week low of $92.99 and a substantial 24.8% below its 52-week high of $143.13. The 1-year price change of +2.74% is deceptive, as the 6-month change of -4.31% and the year-to-date decline of -1.71% reflect more recent weakness, severely underperforming the S&P 500, which is up 22.86% over the past year. This positioning near the lows suggests the stock is in a value-seeking zone but remains a 'falling knife' amid persistent negative momentum. Recent momentum shows a sharp reversal from the lows but remains volatile and weak relative to the market. The stock has gained 9.93% over the past month, which contrasts with the S&P 500's slight decline of -0.08%, indicating a period of relative strength. However, the 3-month performance of +4.96% lags the S&P 500's 12.0% gain, and the 6-month relative strength reading of -13.11% confirms a prolonged period of underperformance. This divergence suggests the recent uptick may be a technical bounce or short-term mean reversion within a broader downtrend rather than a sustainable reversal. Key technical levels are clearly defined, with major support at the 52-week low of $92.99 and resistance at the 52-week high of $143.13. A decisive break below the $93 support level could trigger a new leg down, while a sustained move above the recent February highs near $136 would be necessary to signal a more durable recovery. The stock's beta of 1.21 indicates it is 21% more volatile than the broader market, which, combined with a high short interest ratio of 4.68, suggests the stock is prone to sharp moves and susceptible to short-covering rallies, adding to its risk profile for investors.
Beta
1.21
1.21x market volatility
Max Drawdown
-32.5%
Largest decline past year
52-Week Range
$93-$143
Price range past year
Annual Return
+9.8%
Cumulative gain past year
| Period | MHK Return | S&P 500 |
|---|---|---|
| 1m | +11.5% | +0.3% |
| 3m | +10.0% | +12.3% |
| 6m | +0.1% | +8.9% |
| 1y | +9.8% | +24.0% |
| ytd | -1.3% | +8.7% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
MHK Fundamental Analysis
Mohawk's revenue trajectory shows modest growth but significant pressure on the bottom line. For the most recent quarter (Q4 2025), revenue was $2.70 billion, representing a year-over-year growth of 2.37%. However, this growth has decelerated from the stronger performance seen in prior quarters of 2024, such as Q2 2024 where revenue was $2.80 billion. The Global Ceramic segment, the company's largest, contributed $1.06 billion in the latest period, followed by Carpet and Resilient at $908.7 million and Laminate and Wood at $464.2 million, indicating a diversified but cyclical revenue base. Profitability has deteriorated sharply, with net income collapsing to just $42 million in Q4 2025 from $108.9 million in Q3 2025 and $93.2 million in Q4 2024. The gross margin of 24.57% in the latest quarter shows some resilience but is down from the 25.47% reported in Q2 2025. More critically, the operating margin has compressed to 3.71% in Q4 2025 from 4.92% in the prior-year quarter, reflecting significant operating leverage challenges and rising costs in a softer demand environment. The trailing net margin stands at a thin 3.43%. The balance sheet remains a relative strength, providing some cushion against the operational headwinds. The company maintains a healthy current ratio of 2.19 and a modest debt-to-equity ratio of 0.33. Trailing twelve-month free cash flow is a robust $616.2 million, indicating the business continues to generate significant cash. With a Return on Equity (ROE) of 4.41% and Return on Assets (ROA) of 3.41%, the company's profitability metrics are weak but the strong liquidity position and low leverage provide financial flexibility to weather the current downturn.
Quarterly Revenue
$2.7B
2025-12
Revenue YoY Growth
+0.02%
YoY Comparison
Gross Margin
+0.24%
Latest Quarter
Free Cash Flow
$616200000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is MHK Overvalued?
Given the company's positive but thin net income, the primary valuation metric selected is the Price-to-Earnings (P/E) ratio. The trailing P/E is elevated at 18.35x, while the forward P/E is significantly lower at 10.87x, based on estimated EPS of $15.73. This large gap implies the market is pricing in a substantial recovery in earnings over the next twelve months, expecting profitability to rebound from the depressed Q4 2025 levels. Compared to industry averages, Mohawk's valuation appears mixed. Its Price-to-Sales (P/S) ratio of 0.63 is low, suggesting the market is assigning a discounted multiple to its revenue base, likely due to margin concerns. The trailing P/E of 18.35x is also not excessively high for a cyclical company potentially at a trough, but the forward P/E discount to the trailing figure highlights current earnings weakness. The Enterprise Value to EBITDA multiple of 7.63x further suggests a moderate valuation relative to operating cash flow. Historically, the stock's valuation has compressed significantly. The current Price-to-Book (P/B) ratio of 0.81 is near the lower end of its historical range observed over the past several quarters, which has fluctuated between approximately 0.75 and 1.64. The trailing P/E of 18.35x is below the multi-year highs seen in 2021 (e.g., 48.5x in Q4 2022) but above the deeply depressed levels seen during periods of net losses. Trading near historical lows on a P/B basis suggests the market has already priced in considerable pessimism, potentially offering a margin of safety if fundamentals stabilize.
PE
18.3x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range -3x~49x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
7.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: The primary risk is the severe compression of profitability, with net income collapsing 61% year-over-year in Q4 2025 and operating margins falling to 3.71%. This earnings volatility makes the stock highly sensitive to any further demand weakness or cost inflation. While the balance sheet is strong (D/E of 0.33), the company's revenue is heavily concentrated in the cyclical housing and remodeling sectors, making it vulnerable to prolonged economic softness. The thin net margin of 3.43% offers little buffer against operational missteps.
Market & Competitive Risks: Mohawk trades at a premium trailing P/E of 18.35x despite its earnings collapse, creating valuation compression risk if the expected recovery fails to materialize. Its beta of 1.21 indicates it is 21% more volatile than the market, amplifying downside during sector rotations away from cyclicals. Competitive pressures in the fragmented flooring industry could prevent margin recovery even if demand improves. The stock's high short interest ratio of 4.68 also introduces the risk of exaggerated sell-offs on negative news.
Worst-Case Scenario: A scenario where the housing downturn deepens, leading to further revenue declines and an inability to restore operating leverage, could push the stock to retest its 52-week low of $92.99. Combined with multiple compression as the earnings recovery narrative unravels, this could result in a realistic downside of approximately -14% from the current price of $107.64. A more severe bear case, involving a net loss, could see the stock fall below book value (P/B of 0.81), potentially pushing it toward the $80-$85 range, representing a -20% to -25% decline.
FAQ
The key risks are, in order of severity: 1) Profitability Risk: The severe compression in operating margin to 3.71% may not be temporary; further declines would crush earnings. 2) Cyclical Demand Risk: Revenue is tied to the housing and remodeling markets, which are sensitive to interest rates and consumer confidence. 3) Valuation Compression Risk: If the expected earnings recovery fails, the forward P/E of 10.9x could expand, sending the stock lower. 4) Market & Sentiment Risk: With a beta of 1.21 and high short interest (ratio of 4.68), the stock is volatile and prone to sharp downdrafts on negative news.
The 12-month forecast is highly dependent on the housing cycle and margin trajectory. Our base case (50% probability) sees the stock trading between $115 and $135 as earnings slowly recover. The bull case (30% probability), involving a housing recovery and margin expansion, targets $143 to $171. The bear case (20% probability), where conditions worsen, sees the stock retesting its 52-week low near $93. The most likely scenario is the base case, which assumes a slow, grinding recovery with limited multiple expansion as the market awaits clearer signs of fundamental improvement. The key assumption is that operating margins have bottomed near 3.7% and will stabilize.
MHK sends mixed valuation signals. It appears undervalued on an asset and sales basis, trading below book value (P/B of 0.81) and at a low Price-to-Sales ratio of 0.63. However, on an earnings basis, the trailing P/E of 18.35x seems high given the severe profit collapse. The forward P/E of 10.87x, based on analyst estimates for a sharp earnings recovery, suggests the market is pricing in significant improvement. Overall, the stock is fairly valued relative to its challenged near-term fundamentals but historically cheap on a longer-term basis. The valuation implies the market expects EPS to nearly triple from recent depressed levels, which is a high hurdle.
MHK is a speculative buy for value investors with a high risk tolerance and a multi-year horizon. At current levels, it offers a deep valuation discount (P/S of 0.63, P/B of 0.81) and a strong balance sheet, but it is not a good buy for growth or income investors. The significant 61% year-over-year decline in Q4 net income represents a major headwind. The stock could be a good buy for those who believe the housing cycle will bottom and rebound, allowing margins to recover toward historical levels. However, given the high uncertainty, dollar-cost averaging or waiting for confirmation of margin stabilization in the next earnings report would be prudent.
MHK is unsuitable for short-term trading due to its high volatility (beta of 1.21), lack of dividend, and dependence on cyclical turns that unfold over quarters, not weeks. It is a long-term, cyclical investment best suited for a 3-5 year horizon. Investors must be prepared to endure further volatility while waiting for the housing cycle to inflect and for the company's operational improvements to flow through to the bottom line. The strong free cash flow and solid balance sheet support a long-term hold, but the near-term path is highly uncertain. A minimum holding period of 18-24 months is suggested to see through at least one potential turn in the cycle.